Wednesday, July 8, 2026

Patent intelligence · US

US 11090349

Plant extract obtained from Morus plant leaves, compositions containing same, method of extraction and uses thereof

granted A61KA61K36/605A61K8/9789A61K8/9794
Status granted
Linked drugs 2
Pipeline programs 6
Years to expiry 15
Applicant portfolio 39
Patent details — US 11090349
Jurisdiction
US
Status
granted
Grant date
Aug 17, 2021
Expiration
Aug 12, 2041
Claims
13
CPC classes
A61K, A61K36/605, A61K8/9789, A61K8/9794
View on Google Patents ↗

Quick answer

US 11090349 (Plant extract obtained from Morus plant leaves, compositions containing same, method of extraction and uses thereof) is held by Botanic Century (Beijing) Co. Ltd.. Status: granted. Granted Aug 17, 2021. Expires Aug 12, 2041 (15 years remaining) — relevant for patent-cliff and LOE planning.

Key facts

Grant date
Expiration
Claims
13
CPC classes
A61K, A61K36/605, A61K8/9789, A61K8/9794, A61P, A61P17/00

More from Botanic Century (Beijing) Co. Ltd.

Related pharmaceutical patents in our USPTO index.

  1. US 12274710

    Compound for regulating body weight imbalance, composition thereof and application thereof

    GUANGZHOU CENTURY CLINICAL RESEARCH CO., LTD · Expires Apr 10, 2045

    granted
  2. US 12269888

    Artificial cell death polypeptide for chimeric antigen receptor and uses thereof

    Century Therapeutics, Inc. · Expires Apr 3, 2045

    granted
  3. US 12194049

    Composition for treating carbapenem antibiotic-resistant Acinetobacter baumannii infection

    GUANGZHOU CENTURY CLINICAL RESEARCH CO., LTD · Expires Jan 9, 2045

    granted
  4. US 12084670

    Regulating alkaloids

    22ND CENTURY LIMITED, LLC · Expires Sep 5, 2044

    granted
  5. US 11883432

    Chimeric antigen receptor system with adaptable receptor specificity

    Century Therapeutics, Inc. · Expires Jan 25, 2044

    granted
  6. US 11865155

    Plant extract obtained from Morus plant leaves which has an IC50 value to inhibit a-glucosidase I at a concentration of less than 90 uG/ml, compositions containing same, method of extraction and uses thereof

    Botanic Century (Beijing) Co. Ltd. · Expires Jan 4, 2044

    granted
  7. US 11667924

    Increasing levels of nicotinic alkaloids in plants

    22ND CENTURY LIMITED, LLC · Expires Jun 1, 2043

    granted
  8. US 11661459

    Artificial cell death polypeptide for chimeric antigen receptor and uses thereof

    Century Therapeutics, Inc. · Expires May 25, 2043

    granted

Frequently asked questions

What is US patent 11090349?

US 11090349 (Plant extract obtained from Morus plant leaves, compositions containing same, method of extraction and uses thereof) is held by Botanic Century (Beijing) Co. Ltd.. Status: granted. Granted Aug 17, 2021. Expires Aug 12, 2041 (15 years remaining) — relevant for patent-cliff and LOE planning.

Who owns US 11090349?

Botanic Century (Beijing) Co. Ltd. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 39 pharmaceutical patents for this assignee.

When does US 11090349 expire?

Our index shows an expiration date of Aug 12, 2041 (15 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.